Adriblastin RD 10 mg
Adriblastin RD 10 mg is a medicine authorised by Swissmedic under authorisation number 50357. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 October 1989 and the authorisation is valid without a time limit. ATC code L01DB01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 50357 |
|---|---|
| Name | Adriblastin RD 10 mg |
| Full name | Adriblastin RD 10 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01DB01 |
| First authorisation | 27 October 1989 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Adriblastin RD 10 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | A | 27 October 1989 |
| 3 | Adriblastin RD 50 mg, Pulver zur Herstellung einer Injektionslösung | A | 27 October 1989 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 1 + 1 | Durchstechflasche(n) | L01DB01 | 07.16.1. | A |
| 1 | 1 | Durchstechflasche(n) | L01DB01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Adriblastin RD 10 mg authorised in Switzerland?
Yes. Adriblastin RD 10 mg is authorised by Swissmedic under authorisation number 50357, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Adriblastin RD 10 mg have?
Adriblastin RD 10 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Adriblastin RD 10 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.